Performance Metrics
Real-Time Tracking & Analysis of Treatment Outcomes
Transparent, data-driven measurement of cancer care quality, outcomes, and patient experience to continuously improve and deliver the best possible results.
📊 Six Categories of Performance Metrics
Comprehensive measurement across all dimensions of cancer care excellence
Measuring success through patient outcomes and long-term survival
Key Measurements
5-year survival rates by cancer type and stage
Complete response rates to treatment
Disease-free survival periods
Progression-free survival tracking
Quality of life assessments post-treatment
Recurrence rates and patterns
Our Performance Benchmark
Our 5-year survival rates exceed national averages by 15-20% across major cancer types.
Ensuring excellence through standardized quality measures
Key Measurements
Adherence to evidence-based treatment protocols
Multidisciplinary tumor board review rates
Complication and readmission rates
Patient safety incident tracking
Infection rates and hospital-acquired conditions
Medication error rates
Our Performance Benchmark
Maintaining 98% compliance with National Cancer Institute quality standards.
Reducing wait times and expediting access to care
Key Measurements
Time from diagnosis to treatment initiation
Wait time for specialist consultation
Surgical scheduling within 2 weeks
Same-day urgent appointment availability
Chemotherapy start time after physician order
Imaging and pathology report turnaround
Our Performance Benchmark
Average 14 days from diagnosis to treatment start - 50% faster than national average.
Measuring what matters most to patients
Key Measurements
Overall satisfaction scores (HCAHPS surveys)
Communication effectiveness ratings
Care coordination satisfaction
Pain management effectiveness
Emotional support services rating
Likelihood to recommend scores (NPS)
Our Performance Benchmark
Achieving 95% patient satisfaction rate and Net Promoter Score of +82.
Optimizing resources to serve more patients better
Key Measurements
Treatment capacity utilization rates
Average length of hospital stay
Outpatient clinic throughput
No-show and cancellation rates
Staff-to-patient ratios
Resource allocation optimization
Our Performance Benchmark
Operating at 92% capacity with minimal wait times - industry-leading efficiency.
Advancing cancer care through clinical research
Key Measurements
Clinical trial enrollment rates
Number of active clinical trials
Novel therapy adoption timelines
Research publication output
Successful trial completion rates
Breakthrough designation achievements
Our Performance Benchmark
25% of patients enrolled in clinical trials - 5x the national average.
Transparency You Can Trust
We're proud to share our performance metrics openly, demonstrating our commitment to accountability and continuous improvement in cancer care.